ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $285,853 | -35.6% | 48,286 | -19.3% | 0.00% | – |
Q2 2023 | $444,206 | -52.9% | 59,866 | -40.1% | 0.00% | – |
Q1 2023 | $943,914 | +119.0% | 99,885 | +146.8% | 0.00% | – |
Q4 2022 | $431,037 | +16.5% | 40,473 | -19.3% | 0.00% | – |
Q3 2022 | $370,000 | +58.1% | 50,172 | +3.1% | 0.00% | – |
Q2 2022 | $234,000 | +125.0% | 48,655 | +138.4% | 0.00% | – |
Q1 2022 | $104,000 | -43.5% | 20,408 | -33.2% | 0.00% | – |
Q4 2021 | $184,000 | -52.8% | 30,569 | -30.5% | 0.00% | – |
Q3 2021 | $390,000 | +129.4% | 43,972 | +104.6% | 0.00% | – |
Q2 2021 | $170,000 | +385.7% | 21,489 | +368.3% | 0.00% | – |
Q1 2021 | $35,000 | +34.6% | 4,589 | +39.5% | 0.00% | – |
Q4 2020 | $26,000 | -92.0% | 3,289 | -90.3% | 0.00% | – |
Q3 2020 | $327,000 | – | 33,747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
Sentinus, LLC | 22,500 | $166,000 | 0.10% |
Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
EMFO, LLC | 1,666 | $12,000 | 0.01% |
Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
Jump Financial, LLC | 23,400 | $173,000 | 0.01% |